856905-13-0 Usage
Uses
Used in Pharmaceutical Industry:
3-(PYRAZIN-2-YL)BENZOIC ACID is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new bioactive molecules. Its presence in the molecular structure can enhance the pharmacological properties of drugs, making it an essential component in medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 3-(PYRAZIN-2-YL)BENZOIC ACID is utilized as a precursor in the production of agrochemicals, potentially leading to the creation of novel compounds with applications in pest control and crop protection. Its role in this industry is crucial for developing effective and environmentally friendly solutions for agricultural challenges.
Used in Medicinal Chemistry Research:
3-(PYRAZIN-2-YL)BENZOIC ACID is employed as a subject of interest in drug discovery research due to its demonstrated biological activities. Researchers explore its potential to be incorporated into new therapeutic agents, capitalizing on its ability to influence various biological pathways and processes.
Overall, 3-(PYRAZIN-2-YL)BENZOIC ACID is a multifaceted chemical with applications spanning across different industries, particularly in the development of pharmaceuticals and agrochemicals, where its unique properties are harnessed to create innovative and effective products.
Check Digit Verification of cas no
The CAS Registry Mumber 856905-13-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,6,9,0 and 5 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 856905-13:
(8*8)+(7*5)+(6*6)+(5*9)+(4*0)+(3*5)+(2*1)+(1*3)=200
200 % 10 = 0
So 856905-13-0 is a valid CAS Registry Number.
856905-13-0Relevant academic research and scientific papers
BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS
-
Page/Page column 16, (2010/02/12)
The present invention relates to novel benzazepine derivatives of structure (I) having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
